In the UK, the forecast for Chronic Obstructive Pulmonary Disease (COPD) mortality among women, expressed in standardized rates per hundred thousand, remains stable at 38.1 from 2024 through 2028. This stability reflects no year-on-year percentage change between 2023 and 2024. The absence of variation over this period implies a consistent trend, with the average compound annual growth rate (CAGR) for the past five years remaining at zero. This suggests a stagnation in the improvement or deterioration of COPD mortality rates among women in the UK, indicating steady conditions without significant recent advancements or worsening in outcomes.
Future trends to watch for include the impact of healthcare interventions, public health initiatives focused on smoking cessation and pollution reduction, and potential effects of emerging therapies and technologies targeting respiratory diseases. Monitoring healthcare policy changes and their implementation will be crucial for anticipating changes in COPD mortality rates in subsequent years.
